Bo Cumbo

Bo Cumbo brings more than 28 years of pharmaceutical and biotechnology industry experience, including leading the commercial launches of 11 specialty or rare disease drugs. He has served as the president and chief executive officer of AavantiBio, Inc., a gene therapy company, since October 2020. From 2013 to 2020, Mr. Cumbo held positions of increasing responsibility at Sarepta Therapeutics, Inc., ultimately serving as executive vice president, chief commercial officer. Prior to joining Sarepta in 2013, Mr. Cumbo served as vice president of sales, key account management, and treatment educator teams at Vertex Pharmaceuticals. During his time at Vertex, he led the launch of Incivek, one of the most successful drug launches in the history of U.S. pharmaceuticals. Mr. Cumbo served in multiple commercial roles supporting the HIV, HBV, and cardiovascular franchises at Gilead Sciences. He received his B.S. in Laboratory Technology from Auburn University.